Role of risk factors, clinical features and treatment modality in early detection and management of Buerger’s disease: a study from tertiary care centre Pondicherry

Krithika Kiruba, Himadra Koranga, Chandrasekaran Ramaraj, Anant A. Takalkar


Background: Thromboangiitis obliterans is a disease of unknown aetiology seen under 45 years of age with no form of treatment has been successful in offering the victims of this disease a cure nor even a long-term remission. Objective of the study was to study the role of different risk factors, clinical features and treatment modality in early detection and management of Buerger’s disease.

Methods: This is an experimental study carried out in 50 cases of Buerger’s disease after obtaining a well-informed written consent in department of General Surgery in Aarupadai Veedu Medical College and Hospital. Period of study was from October 2015 to October 2017. Data was analysed with SPSS 23.0 version.

Results: Majority were from 31-40 years age group i.e. 30 (60%). Left lower limb was involved in 52% subjects. 80% smoked more than 20 cigarettes per day. Signs of ischemia was present in all 50 patients. Gangrene of the limb was seen in 14 patients (28%). Out of 3 patients with recurrent pain, 2 (66.7%) were relieved. Ulcer healing occurred in 5 out of 6 patients i.e. 83.3% and intermittent claudication was relieved in 2 out of 7 patients i.e. 28.6%.

Conclusions: Males are commonly involved in our study. Majority of patients were in age group 31-40 years. Smoking is an important and definite risk factor in relation with the development of Buerger’s disease. Lower limb is commonly involved. Majority of patients in our series were treated by conservative management.


Buerger’s disease, Clinical features, Risk factors, Treatment

Full Text:



Buerger L. Thromboangiitis obliterans:a study of the vascular lesions leading to presenile gangrene. Am J Med Sci. 1908;136:567-80.

Buerger L. The circulatory disturbance of the extremities: including gangrene, vasomotor and trophic disorders. Philadelphia: Saunders; 1924.

Olin JW, Young JR, Graor RA, Ruschhaupt WF, Bartholomew JR. The changing clinical spectrum of thromboangiitis obliterans (Buerger's disease). Circulation. 1990;82(4):3-8.

Lie JT. Diagnostic histopathology of major systemic and pulmonary vasculitis syndromes. Rheum Dis Clin North Am. 1990;16:269-92.

Alpaslan M, Akgun G, Doven O, Oral D. Thrombus in the main pulmonary artery of a patient with thromboangiitis obliterans: Observation by transthoracic echocardiography. Eur J Echocardiogr. 2001;2:139-40.

Shionoya S, Ban I, Nakata Y, Matsubara J, Hirai M, Kawai S. Involvement of the iliac artery in Buerger’s disease (pathogenesis and arterial reconstruction). J Cardiovasc Surg (Torino). 1978;19:69-76.

Matsushita M, Nishikimi N, Sakurai T, Nimura Y. Decrease in prevalence of Buerger’s disease in Japan. Surgery. 1998;124:498-502.

Olin JW. Thromboangiitis obliterans (Buerger's disease). N Engl J Med. 2000;343(12):864-9.

Mills JL, Taylor LM, Porter JM. Buerger's disease in the modern era. Am J Surg. 1987;154(1):123-9.

Telford ED, Stopford JS. Thrombo-angiitis obliterans: with special reference to its pathology and the results of sympathectomy. Br Med J. 1935;1(3877):863.

Homans J, Zollinger R. Experimental Thrombophlebitis. Arch Surg. 1929;18:992.

Wright IS. The Treatment of Occlusive Arterial Disease: Viewpoint of an Internist. JAMA. 1963;183(3):186-91.

Hooten WM, Bruns HK, Hays JT. Inpatient treatment of severe nicotine dependence in a patient with thromboangiitis obliterans (Buerger's disease). In Mayo Clinic Proceedings. 1998;73(6):529-32.

Akhtar S, Jyotsna G, Raghvendra G. Chronic Smoking and Buerger’s Disease: A Hospital Based Study. Chronic Smoking and Buerger’s Disease: A Hospital Based Study. IOSR J Pharma Biological Sci. 2013;5(2):49-54.

Erb W. Ueber dysbasia angiosclerotica ("intermittierendes Hinken"). Mnch Med Wochenschr. 1904;51:905-8.

Silbert S. Thrombo-angiitis obliterans (Buerger): treatment of 524 cases by repeated intravenous injections of hypertonic salt solution:experience of 10 years. Surg Gynecol Obstet. 1935;51:214-22.

Mitchell GAG. In: Martin P, Lynn RB, Dible JH, Aird I. Peripheral Vascular Discorders. Edinburgh and London: Livingston; 1956: 1-7.

Richards RL. Thrombo-angiitis obliterans (Buerger's Disease) in the west of Scotland. Scottish Med J. 1972;17(2):50-6.

Gillespie RL, Mullen GM, Costanzo-Nordin MR. Arterial microembolisation: an unusual presentation of dilated cardiomyopathy. Heart. 1990;63(1):63-5.

Kaltari DK. Clinical study Evaluation and Management of Buerger's Disease (Thromboangiitis Obliterans). Personal communication, RGUHS, 2006.

Persson AV, Anderson LA, Padberg FT Jr. Selection of patients for lumbar sympathectomy. Surgical Clin N Am. 1985;65:393.

Lee BY, Madden JL, Tuoden WR, McCann WJ. Lumbar sympathectomy for toe gangrene, long term-follow up. Am J Surg. 1983;145:398-401.

Nesargikar PN, Ajit MK, Eyers PS, Nichols BJ, Chester JF. Lumbar chemical sympathectomy in peripheral vascular disease: does it still have a role? Int J Surg. 2009;7(2):145-9.